| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.082 | 0.007 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |